Literature DB >> 18521339

Statistical classification strategy for proton magnetic resonance spectra of soft tissue sarcoma: an exploratory study with potential clinical utility.

Tedros Bezabeh1, Samy El-Sayed, Rakesh Patel, Ray L Somorjai, Vivien Bramwell, Rita Kandel, Ian C P Smith.   

Abstract

PURPOSE: Histological grading is currently one of the best predictors of tumor behavior and outcome in soft tissue sarcoma. However, occasionally there is significant disagreement even among expert pathologists. An alternative method that gives more reliable and non-subjective diagnostic information is needed. The potential use of proton magnetic resonance spectroscopy in combination with an appropriate statistical classification strategy was tested here in differentiating normal mesenchymal tissue from soft tissue sarcoma.
METHODS: Fifty-four normal and soft tissue sarcoma specimens of various histological types were obtained from 15 patients. One-dimensional proton magnetic resonance spectra were acquired at 360 MHz. Spectral data were analyzed by using both the conventional peak area ratios and a specific statistical classification strategy.
RESULTS: The statistical classification strategy gave much better results than the conventional analysis. The overall classification accuracy (based on the histopathology of the MRS specimens) in differentiating normal mesenchymal from soft tissue sarcoma was 93%, with a sensitivity of 100% and specificity of 88%.The results in the test set were 83, 92 and 76%, respectively. Our optimal region selection algorithm identified six spectral regions with discriminating potential, including those assigned to choline, creatine, glutamine, glutamic acid and lipid.
CONCLUSION: Proton magnetic resonance spectroscopy combined with a statistical classification strategy gave good results in differentiating normal mesenchymal tissue from soft tissue sarcoma specimens ex vivo. Such an approach may also differentiate benign tumors from malignant ones and this will be explored in future studies.

Entities:  

Year:  2002        PMID: 18521339      PMCID: PMC2395484          DOI: 10.1080/1357714021000065396

Source DB:  PubMed          Journal:  Sarcoma        ISSN: 1357-714X


  33 in total

1.  Near-optimal region selection for feature space reduction: novel preprocessing methods for classifying MR spectra.

Authors:  A E Nikulin; B Dolenko; T Bezabeh; R L Somorjai
Journal:  NMR Biomed       Date:  1998 Jun-Aug       Impact factor: 4.044

Review 2.  Imaging of soft tissue sarcomas.

Authors:  M J Heslin; J K Smith
Journal:  Surg Oncol Clin N Am       Date:  1999-01       Impact factor: 3.495

3.  Gradient, high-resolution, magic-angle spinning nuclear magnetic resonance spectroscopy of human adipocyte tissue.

Authors:  K K Millis; W E Maas; D G Cory; S Singer
Journal:  Magn Reson Med       Date:  1997-09       Impact factor: 4.668

4.  Classification of human liposarcoma and lipoma using ex vivo proton NMR spectroscopy.

Authors:  K Millis; P Weybright; N Campbell; J A Fletcher; C D Fletcher; D G Cory; S Singer
Journal:  Magn Reson Med       Date:  1999-02       Impact factor: 4.668

Review 5.  New diagnostic modalities in soft tissue sarcoma.

Authors:  S Singer
Journal:  Semin Surg Oncol       Date:  1999 Jul-Aug

Review 6.  Prognostic factors in soft tissue sarcoma.

Authors:  E A Levine
Journal:  Semin Surg Oncol       Date:  1999 Jul-Aug

7.  Diagnosis and prognosis of breast cancer by magnetic resonance spectroscopy of fine-needle aspirates analysed using a statistical classification strategy.

Authors:  C E Mountford; R L Somorjai; P Malycha; L Gluch; C Lean; P Russell; B Barraclough; D Gillett; U Himmelreich; B Dolenko; A E Nikulin; I C Smith
Journal:  Br J Surg       Date:  2001-09       Impact factor: 6.939

8.  Magnetic resonance spectroscopy of the malignant prostate gland after radiotherapy: a histopathologic study of diagnostic validity.

Authors:  C Menard; I C Smith; R L Somorjai; L Leboldus; R Patel; C Littman; S J Robertson; T Bezabeh
Journal:  Int J Radiat Oncol Biol Phys       Date:  2001-06-01       Impact factor: 7.038

9.  Metastasis-associated alterations in phospholipids and fatty acids of human prostatic adenocarcinoma cell lines.

Authors:  R Dahiya; B Boyle; B C Goldberg; W H Yoon; B Konety; K Chen; T S Yen; W Blumenfeld; P Narayan
Journal:  Biochem Cell Biol       Date:  1992-07       Impact factor: 3.626

10.  Tissue characterization and assessment of preoperative chemotherapeutic response in musculoskeletal tumors by in vivo 31P magnetic resonance spectroscopy.

Authors:  O M Redmond; E Bell; J P Stack; P A Dervan; D N Carney; B Hurson; J T Ennis
Journal:  Magn Reson Med       Date:  1992-10       Impact factor: 4.668

View more
  3 in total

1.  Prediction of treatment response in head and neck cancer by magnetic resonance spectroscopy.

Authors:  Tedros Bezabeh; Olva Odlum; Richard Nason; Paul Kerr; Donna Sutherland; Rakesh Patel; Ian C P Smith
Journal:  AJNR Am J Neuroradiol       Date:  2005-09       Impact factor: 3.825

2.  In Vivo Brain Magnetic Resonance Spectroscopy: A Measurement of Biomarker Sensitivity to Post-Processing Algorithms.

Authors:  Daniel Cocuzzo; Alexander Lin; Peter Stanwell; Carolyn Mountford; Nirmal Keshava
Journal:  IEEE J Transl Eng Health Med       Date:  2014-03-03       Impact factor: 3.316

Review 3.  On the Relevance of Soft Tissue Sarcomas Metabolic Landscape Mapping.

Authors:  Miguel Esperança-Martins; Iola F Duarte; Mara Rodrigues; Joaquim Soares do Brito; Dolores López-Presa; Luís Costa; Isabel Fernandes; Sérgio Dias
Journal:  Int J Mol Sci       Date:  2022-09-28       Impact factor: 6.208

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.